Evidence map›Paper›PMID 31722712›Full record

ArticleMolecular cancer2019

circLMTK2 acts as a sponge of miR-150-5p and promotes proliferation and metastasis in gastric cancer.

Sen Wang, Dong Tang, Wei Wang, Yining Yang, Xiaoqing Wu, Liuhua Wang, Daorong Wang

Open access · goldAbstract read
In one paragraph

Article in Molecular cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Gastric Cancer in the Era of Epigenetics.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. METTL14-mediated mMolecular cancer · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sen WangDepartment of General Surgery, Northern Jiangsu People's Hospital, Yangzhou University, Yangzhou, 225001, Jiangsu, China.
Dong TangDepartment of General Surgery, Northern Jiangsu People's Hospital, Yangzhou University, Yangzhou, 225001, Jiangsu, China.
Wei WangDepartment of General Surgery, Northern Jiangsu People's Hospital, Yangzhou University, Yangzhou, 225001, Jiangsu, China.
Yining YangGloriousMed Technology Co., Ltd., Shanghai, 200120, China.
Xiaoqing WuDepartment of General Surgery, Northern Jiangsu People's Hospital, Yangzhou University, Yangzhou, 225001, Jiangsu, China.
Liuhua WangDepartment of General Surgery, Northern Jiangsu People's Hospital, Yangzhou University, Yangzhou, 225001, Jiangsu, China.
Daorong WangDepartment of General Surgery, Northern Jiangsu People's Hospital, Yangzhou University, Yangzhou, 225001, Jiangsu, China. wdaorong666@sina.com.
Northern Jiangsu People's Hospital · CNYangzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAs a novel class of non-coding RNAs, circular RNAs (circRNAs) are key regulators of the development and progression of different cancers. However, little is known about the function and biological mechanism of circLMTK2, also named hsa_circ_0001725, in gastric cancer (GC) tumourigenesis.

methodscircLMTK2 was identified in ten paired cancer specimens and adjacent normal tissues by RNA sequencing and genome-wide bioinformatic analysis and verified by quantitative real-time PCR (qRT-PCR). Knockdown or exogenous expression of circLMTK2 combined with in vitro and in vivo assays were performed to prove the functional significance of circLMTK2. The molecular mechanism of circLMTK2 was demonstrated by searching the CircNet database and confirmed by RNA in vivo precipitation assays, western blotting, luciferase assays and rescue experiments.

resultscircLMTK2 was frequently upregulated in GC tissues, and high circLMTK2 expression was associated with poor prognosis, lymph node metastasis and poor TNM stage in GC patients. Functionally, circLMTK2 overexpression promoted GC cell proliferation and tumourigenicity in vitro and in vivo. Furthermore, ectopic circLMTK2 expression enhanced GC cell migration and invasion in vitro and tumour metastasis in vivo. In addition, we demonstrated that circLMTK2 could sponge miR-150-5p, thus indirectly regulating the c-Myc expression and contributing to GC tumourigenesis.

conclusionOur findings demonstrate that circLMTK2 functions as a tumour promoter in GC through the miR-150-5p/c-Myc axis and could thus be a prognostic predictor and therapeutic target for GC.

Indexed as

RNA, CircularAdultAgedCell Line, TumorCell ProliferationCell Transformation, NeoplasticDisease ProgressionFemaleGene Expression Regulation, NeoplasticHigh-Throughput Nucleotide SequencingHumansLymphatic MetastasisMaleMembrane ProteinsMicroRNAsMiddle AgedLMTK2 protein, humanMembrane ProteinsMicroRNAsMIR150, humanProtein Serine-Threonine KinasesRNA, CircularcircLMTK2C-MycGastric cancermiR-150-5p

Identifiers

PMID31722712
PMCPMC6854648
OpenAlexW2983319347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.